EWTX
EWTX
US28036F1057
Edgewise Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
191.406.000 158.832.000
20.5%
Operating Income -191.406.000 -158.832.000
20.5%
Pretax Income -167.795.000 -133.813.000
25.4%
Net Income Common Stockholders -167.795.000 -133.813.000
25.4%
-- --
--
-- --
--
ende